title: [Clinical analysis of short-term efficacy in senile sudden deafness].
abstract: OBJECTIVE
  To analysis the short-term medicinal treating effects in senile sudden deafness.
  
  
  METHODS
  According the age. The sudden deafness patients were divided into to groups, older age-group (age > or = 60, a total of 70 cases), control group (age < 60, a total of 70 cases), period of treatment was 7 days, the result of pure tone test were reviewed, compared the improvement before and after treatment.
  
  
  RESULTS
  After treatment, the average hearing threshold of the older age-patients was improved. There was statistical difference (P < 0.05); effective rate of the senile sudden deafness patients (disease time < or = 7 days) was 61.76%, (disease time > 7 days) was 38.89%. There was statistical difference (P < 0.05); the total effective rate of the senile sudden deafness patients was 49.9%; the senile sudden deafness patients which following moderate deafness (hearing threshold < 55 dB), effective rate was 52%, control group was 84.62%. There was statistical difference (P < 0.05), but there was no significant difference in the patients with severe hearing loss.
  
  
  CONCLUSIONS
  The Course of disease has important significance for the prognosis of the senile sudden deafness patients. As soon as possible to improve peripheral vascular microcirculation, the prognosis could be improve conspicuously the prognosis of the senile sudden deafness patients were worse than the young patients.
authors.forename: Xiaojun
authors.initials: X
authors.lastname: Zhang
authors.forename: Jianyong
authors.initials: J
authors.lastname: Zhou
authors.forename: Guopeng
authors.initials: G
authors.lastname: Tan
authors.forename: L V
authors.initials: LV
authors.lastname: Jieyu
authors.forename: Feipeng
authors.initials: F
authors.lastname: Yan
mesh_terms: D000367:Age Factors; D000368:Aged; D003131:Combined Modality Therapy; D005260:Female; D003639:Hearing Loss, Sudden / Q000628:therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011304:Presbycusis / Q000628:therapy*; D016896:Treatment Outcome